Clinical Trial Update: Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating potassium chloride for out-of-hospital cardiac arrest due to refractory ventricular fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Out-of-hospital Cardiac Arrest

Drugs mentioned

• Potassium chloride (Potassium chloride)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Out-of-hospital Cardiac Arrest (OHCA) | Phase 2 | Status: WITHDRAWN